- Home
- OSIS vs RGC Comparison
OSIS vs RGC Comparison
Compare OSIS & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OSIS | RGC |
|---|---|---|
| Founded | 1987 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.1B |
| IPO Year | 1997 | 2020 |
Fundamental Metrics
Financial Performance| Metric | OSIS | RGC |
|---|---|---|
| Price | $197.16 | $6.37 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $278.29 | N/A |
| AVG Volume (30 Days) | ★ 180.3K | 155.6K |
| Earning Date | 10-29-2026 | 10-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2.76 | N/A |
| EPS | ★ 8.95 | N/A |
| Revenue | ★ $1,089,286,000.00 | N/A |
| Revenue This Year | $6.84 | N/A |
| Revenue Next Year | $6.42 | N/A |
| P/E Ratio | $21.46 | ★ N/A |
| Revenue Growth | ★ 13.35 | N/A |
| 52 Week Low | $186.50 | $4.51 |
| 52 Week High | $311.72 | $69.00 |
Technical Indicators
Market Signals| Indicator | OSIS | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 37.08 | 54.01 |
| Support Level | $186.50 | $5.48 |
| Resistance Level | $206.19 | $6.28 |
| Average True Range (ATR) | 5.55 | 0.28 |
| MACD | -0.12 | 0.05 |
| Stochastic Oscillator | 25.42 | 80.43 |
Price Performance
Historical ComparisonAbout OSIS OSI Systems Inc. (DE)
OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems, and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. The majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East and Africa, and the Asia Pacific regions.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.